96-6044. Availability of Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Concerning a Microsphere Drug Application Device

[Federal Register Volume 61, Number 51 (Thursday, March 14, 1996)]
[Notices]
[Page 10567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-6044]



-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Availability of Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning a Microsphere Drug Application 
Device

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 5,470,311 entitled 
``Microsphere Drug Application Device'' and issued on November 28, 
1995. This patent has been assigned to the United States Government as 
represented by the Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Staff Judge Advocate, Fort Detrick, Frederick, Maryland 21702-
5012.

FOR FURTHER INFORMATION CONTACT:
Mr. Werten F.W. Bellamy, U.S. Army Intellectual Property Law Division, 
901 North Stuart Street, ATTN: JALS-IP, Arlington, Virginia 22203-1837, 
voice phone [phone] or telefax [phone].

SUPPLEMENTARY INFORMATION: The invention includes an apparatus and 
methods for dispensing medicinals encapsulated in a biodegradable 
polymer in surgical and other wounds. The apparatus, a microcapsule 
drug applicator, allows the caregiver to implant or spread measured and 
uniform quantities of microencapsulated medicinals in or on surgical or 
traumatic wounds to prevent and/or treat infections. Specific examples 
where microencapsulated antibiotics may prove useful include: soft-
tissue wounds; following debridement and reduction or fixation of open 
fractures; to osteomyelitic bone after surgical debridement; after 
surgical insertion of prostheses such as hip/knee replacements 
(arthroplasty); and following vascular surgery or grafting.
Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 96-6044 Filed 3-13-96; 8:45 am]
BILLING CODE 3710-08-M